MULTIPLE SCLEROSIS RELAPSE

Adverse reaction reported in 78,873 FDA reports across 20 drugs.

78,873

Total Reports

Drugs Involved

Natalizumab

Most Reported Drug

Drugs Associated with MULTIPLE SCLEROSIS RELAPSE

Drugs where "MULTIPLE SCLEROSIS RELAPSE" was reported as an adverse event.

#	Drug	Reports	% of Total
1	Natalizumab	16,845	21.4%
2	Interferon Beta-1a	15,823	20.1%
3	Dimethyl	8,097	10.3%
4	Fingolimod	7,711	9.8%
5	Teriflunomide	5,225	6.6%
6	Glatiramer	5,137	6.5%
7	Dalfampridine	4,766	6.0%
8	Baclofen	3,406	4.3%
9	Ocrelizumab	2,661	3.4%
10	Ofatumumab	1,661	2.1%
11	Interferon Beta-1b	1,343	1.7%
12	Peginterferon Beta-1a	969	1.2%
13	Diroximel	953	1.2%
14	Alemtuzumab	907	1.1%
15	Modafinil	865	1.1%
16	Ozanimod	577	0.7%
17	Tizanidine	545	0.7%
18	Siponimod	532	0.7%
19	Cladribine	468	0.6%
20	Amantadine	382	0.5%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. The presence of a drug in this list does not mean the drug caused multiple sclerosis relapse. Always consult your healthcare provider.